What Is the government doing to cardiology? Marlon G. RamiloGerald M. Pohost Editor’s Commentary Pages: 307 - 308
Complications associated with implantable cardioverter defibrillator replacements associated with recalls Michael R. Gold Clinical Trials Report Pages: 313 - 313
Catheter ablation for chronic atrial fibrillation Michael R. Gold Clinical Trials Report Pages: 313 - 314
Cardiac resynchronization therapy for heart failure Michael R. Gold Clinical Trials Report Pages: 314 - 315
Sudden cardiac death in Athletes Olaf HedrichMark Estes IIIMark S. Link OriginalPaper Pages: 316 - 322
Cardiac resynchronization therapy: Role of patient selection Alan J. BankAaron S. KellyStuart W. Adler OriginalPaper Pages: 336 - 342
Use of beta-blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers to prevent atrial fibrillation Kristian WachtellRichard B. DevereuxPaulette A. Lyle OriginalPaper Pages: 356 - 364
Is there a role for antiarrhythmic drugs in patients with implantable defibrillators? Andrew HoRamin AssadiRamdas G. Pai OriginalPaper Pages: 365 - 369
Atrial fibrillation: Choosing an antiarrhythmic drug Todd RudoPeter Kowey OriginalPaper Pages: 370 - 376
Restoring normal sinus rhythm in atrial fibrillation: Evidence from pharmacologic therapy and catheter ablation trials Peter Zimetbaum OriginalPaper Pages: 377 - 386